Search Results 91-100 of 17041 for monoclonal antibody
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...
The purpose of this study is to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in ...
Rituximab injection is a monoclonal antibody. Rituximab injection is used together with other medicines (eg, fludarabine cyclophosphamide) to treat chronic ...
... monoclonal antibody that targets CD38, a protein found on the surface of myeloma cells, significantly reduces the risk of progression to active multiple ...
From protective measures to monoclonal antibody therapy and other treatments, Dr. ... monoclonal antibodies. Or for patients who require hospitalization ...
Certain medicines, such as monoclonal antibodies and medicines to suppress the immune system after a transplant. Autoimmune encephalitis is more likely to ...
About this study. The purpose of this study is to investigate whether clazakizumab (an anti-interleukin (IL)-6 monoclonal antibody (mAb)) may be beneficial ...
... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. Idecabtagene vicleucel injection is an antineoplastic ...
... monoclonal antibody therapy in some cases. If you have this treatment, do you still develop your own antibodies and long-term protection? And does having ...
... monoclonal antibody therapy prior to anti-EGFR monoclonal antibody therapy. For those with left-sided tumors, the data are less clear. However, we at least ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.